(Q33963576)

30 July 2017

1 reference

title

Adriamycin-induced heart failure: mechanism and modulation (English)

1 reference

30 July 2017

0 references

Singal PK

1

1 reference

30 July 2017

Li T

2

1 reference

30 July 2017

Kumar D

3

1 reference

30 July 2017

Danelisen I

4

1 reference

30 July 2017

Iliskovic N

5

1 reference

30 July 2017

publication date

1 April 2000

1 reference

Molecular and Cellular Biochemistry

30 July 2017

published in

1 reference

30 July 2017

volume

207

1 reference

30 July 2017

issue

1-2

1 reference

30 July 2017

page(s)

77-86

1 reference

Effect of anthracycline antibiotics on oxygen radical formation in rat heart

30 July 2017

cites work

1 reference

12 December 2020

Probucol scavenged 1,1-diphenyl-2-picrylhydrazyl radicals and inhibited formation of thiobarbituric acid reactive substances

1 reference

12 December 2020

Adriamycin (NSC-123,127): a new antibiotic with antitumor activity

1 reference

12 December 2020

Anthracycline antibiotics in cancer therapy. Focus on drug resistance

1 reference

12 December 2020

Risk factors for doxorubicin-induced congestive heart failure

1 reference

12 December 2020

Dexrazoxane in the prevention of doxorubicin-induced cardiotoxicity

1 reference

12 December 2020

Regulatory role of glutathione and soluble sulfhydryl groups in the toxicity of adriamycin

1 reference

12 December 2020

The anthracycline antineoplastic drugs

1 reference

12 December 2020

The effect of doxorubicin on hepatic and cardiac glutathione

1 reference

12 December 2020

Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: the Probucol Angioplasty Restenosis Trial

1 reference

12 December 2020

Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure.

1 reference

12 December 2020

ICRF-187 permits longer treatment with doxorubicin in women with breast cancer

1 reference

12 December 2020

Evaluation of free radical effects and catecholamine alterations in adriamycin cardiotoxicity

1 reference

12 December 2020

Relation between serum-free-fatty acids and arrhythmias and death after acute myocardial infarction

1 reference

12 December 2020

Adriamycin stimulates low-affinity Ca2+ binding and lipid peroxidation but depresses myocardial function

1 reference

12 December 2020

Hypocholestece:rolesmic Effect of 4,4′-(Isopropylidenedithio)-Bis(2,6-di-t-Butylphenol) (Probucol)

1 reference

12 December 2020

Adriamycin-induced cardiotoxicity (cardiomyopathy and congestive heart failure) in rats

1 reference

12 December 2020

Myocardial adrenergic changes at two stages of heart failure due to adriamycin treatment in rats

1 reference

12 December 2020

Changes in lysosomal morphology and enzyme activities during the development of adriamycin-induced cardiomyopathy

1 reference

12 December 2020

Enzymatic defenses of the mouse heart against reactive oxygen metabolites: alterations produced by doxorubicin

1 reference

12 December 2020

Adriamycin-induced lipid peroxidation in mitochondria and microsomes

1 reference

12 December 2020

Free radicals and the heart

1 reference

12 December 2020

Reduced cardiotoxicity of doxorubicin by a 6-hour infusion regimen. A prospective randomized evaluation

1 reference

12 December 2020

A randomized controlled trial assessing the prevention of doxorubicin cardiomyopathy by N-acetylcysteine

1 reference

12 December 2020

Prevention of doxorubicin myocardial toxicity in mice by reduced glutathione

1 reference

12 December 2020

Direct effects of adriamycin on the rat heart sarcolemma

1 reference

12 December 2020

Characterization of the cycle of iron-mediated electron transfer from Adriamycin to molecular oxygen

1 reference

12 December 2020

Antagonistic effect of the cardioprotector (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187) on DNA breaks and cytotoxicity induced by the topoisomerase II directed drugs daunorubicin and etoposide (VP-16)

1 reference

12 December 2020

Anthracycline antibiotic-stimulated superoxide, hydrogen peroxide, and hydroxyl radical production by NADH dehydrogenase

1 reference

12 December 2020

Pulse radiolysis studies of antitumor quinones: Radical lifetimes, reactivity with oxygen, and one-electron reduction potentials

1 reference

12 December 2020

Cardiac toxicity 4 to 20 years after completing anthracycline therapy

1 reference

12 December 2020

Acute and chronic cardiovascular effects of doxorubicin in the dog: the cardiovascular pharmacology of drug-induced histamine release.

1 reference

12 December 2020

The effect of a high molar FFA/albumin ratio in the perfusion medium on rhythm and contractility of the isolated rat heart

1 reference

12 December 2020

Failure of the antioxidant vitamin E to protect against adriamycin-induced cardiotoxicity in the rabbit

1 reference

12 December 2020

Cardiac disease induced by chronic adriamycin administration in dogs and an evaluation of vitamin E and selenium as cardioprotectants

1 reference

12 December 2020

Apoptosis in human acute myocardial infarction

1 reference

12 December 2020

Model Systems for Cardiotoxic Effects of Anthracyclines

1 reference

12 December 2020

Hyperlipidemic effects of adriamycin in rats

1 reference

12 December 2020

Antioxidant activity of probucol and its analogues in hypercholesterolemic Watanabe rabbits

1 reference

12 December 2020

Mechanisms of beneficial effects of probucol in adriamycin cardiomyopathy

1 reference

12 December 2020

Adriamycin-induced cardiac damage in the mouse: a small-animal model of cardiotoxicity

1 reference

12 December 2020

Direct detection of paramagnetic species in adriamycin perfused rat hearts

1 reference

12 December 2020

A relative deficit in antioxidant reserve may contribute in cardiac failure

1 reference

12 December 2020

Probucol: pharmacology and clinical application

1 reference

12 December 2020

Prospective evaluation of cardiotoxicity during a six-hour doxorubicin infusion regimen in women with adenocarcinoma of the breast

1 reference

12 December 2020

Carnitine--metabolism and functions

1 reference

12 December 2020

Nuclear catalyzed antibiotic free radical formation

1 reference

12 December 2020

Myocardial injury induced by a single dose of adriamycin: an electron microscopic study

1 reference

12 December 2020

Hydroxyl radical production and DNA damage induced by anthracycline-iron complex

1 reference

12 December 2020

Combined effects of cholestyramine and probucol on regression of atherosclerosis in rhesus monkey aortas

1 reference

12 December 2020

Deoxyribose breakdown by the adriamycin semiquinone and H2O2: evidence for hydroxyl radical participation

1 reference

12 December 2020

Early anthracycline cardiotoxicity

1 reference

12 December 2020

Adriamycin, 14-hydroxydaimomycin, a new antitumor antibiotic fromS. Peucetius var.caesius

1 reference

12 December 2020

Doxorubicin-induced cardiomyopathy

1 reference

12 December 2020

Phase I study of ICRF-187 using a daily for 3 days schedule

1 reference

12 December 2020

dl-N,N'-dicarboxamidomethyl-N,N'-dicarboxymethyl-1,2-diaminopropane (ICRF-198) and d-1,2-bis(3,5-dioxopiperazine-1-yl)propane (ICRF-187) inhibition of Fe3+ reduction, lipid peroxidation, and CaATPase inactivation in heart microsomes exposed to adria

1 reference

12 December 2020

Cardiac ultrastructural changes induced by daunorubicin therapy.

1 reference

12 December 2020

Probucol protects against adriamycin cardiomyopathy without interfering with its antitumor effect

1 reference

12 December 2020

An anthracycline antibiotic-induced cardiomyopathy in rabbits

1 reference

12 December 2020

Modulation of adriamycin-induced changes in serum free fatty acids, albumin and cardiac oxidative stress

1 reference

12 December 2020

Phase I and preliminary phase II evaluation of adriamycin (NSC 123127)

1 reference

12 December 2020

Vitamin E deficiency accentuates adriamycin-induced cardiomyopathy and cell surface changes

1 reference

12 December 2020

Lipid lowering: an important factor in preventing adriamycin-induced heart failure

1 reference

12 December 2020

Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study Group

1 reference

12 December 2020

Free radicals induced by adriamycin-sensitive and adriamycin-resistant cells: a spin-trapping study.

1 reference

12 December 2020

Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response

1 reference

12 December 2020

Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats

1 reference

12 December 2020

Adriamycin-induced myocardial lesions Report of a Workshop

1 reference

12 December 2020

Subcellular effects of adriamycin in the heart: a concise review

1 reference

12 December 2020

Effects of probucol on xanthomata regression in familial hypercholesterolemia

1 reference

12 December 2020

Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion

1 reference

12 December 2020

A clinicopathologic analysis of adriamycin cardiotoxicity

1 reference

12 December 2020

Fine structural changes in rat myocardium induced by daunorubicin

1 reference

12 December 2020

Probucol inhibits oxidative modification of low density lipoprotein

1 reference

12 December 2020

Biochemical determinants of Adriamycin toxicity in mouse liver, heart and intestine

1 reference

12 December 2020

Inhibition of sodium-potassium-activated adenosine 5'-triphosphatase and ion transport by adriamycin

1 reference

12 December 2020

Doxorubicin-induced apoptosis in spontaneously hypertensive rats: differential effects in heart, kidney and intestine, and inhibition by ICRF-187.

1 reference

12 December 2020

Plasma lipoproteins and renal apolipoproteins in rats with chronic adriamycin nephrosis.

1 reference

12 December 2020

Modifications in glomerular polyanion distribution in adriamycin nephrosis

1 reference

12 December 2020

Electrolyte and morphologic alterations of myocardium in adriamycin-treated rabbits.

1 reference

12 December 2020

Ascorbic acid and adriamycin toxicity

1 reference

12 December 2020

Refractory heart failure and age-related differences in adriamycin-induced myocardial changes in rats

1 reference

12 December 2020

The anthracyclines: will we ever find a better doxorubicin?

1 reference

12 December 2020

Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteine

1 reference

12 December 2020

Reduction of chronic doxorubicin cardiotoxicity in dogs by pretreatment with (+/-)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187)

1 reference

12 December 2020

Combination therapy with probucol prevents adriamycin-induced cardiomyopathy

1 reference

12 December 2020

Effects of Adriamycin on heart mitochondrial function in rested and exercised rats

1 reference

12 December 2020

Doxorubicin cardiotoxicity in children: comparison of a consecutive divided daily dose administration schedule with single dose (rapid) infusion administration

1 reference

12 December 2020

Adriamycin cardiomyopathy: pathophysiology and prevention

1 reference

12 December 2020

Free radical production from normal and adriamycin-treated rat cardiac sarcosomes

1 reference

12 December 2020

Spin-trapping and direct electron spin resonance investigations of the redox metabolism of quinone anticancer drugs

1 reference

12 December 2020

Apoptosis in isolated adult cardiomyocytes exposed to adriamycin

1 reference

12 December 2020

Glutathione peroxidase activity and selenium concentration in the hearts of doxorubicin-treated rabbits

1 reference

12 December 2020

Apoptosis in myocytes in end-stage heart failure

1 reference

12 December 2020

Probucol improves antioxidant activity and modulates development of diabetic cardiomyopathy

1 reference

12 December 2020

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1007094214460

1 reference

Dimensions Publication ID

30 July 2017

1022163922

0 references

1 reference